monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD), covering 2015-07-20 to 2015-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults [Phase 1]